Ascendis Pharma A/S
Biopharmaceutical firm using its prodrug technology to treat rare diseases.
ASND | US
Overview
Corporate Details
- ISIN(s):
- US04351P1012
- LEI:
- Country:
- United States of America
- Address:
- TUBORG BOULEVARD 12, 0 HELLERUP
- Website:
- https://ascendispharma.dk/
- Sector:
- Manufacturing
Description
Ascendis Pharma is a biopharmaceutical company that applies its proprietary TransCon (Transient Conjugation) technology platform to develop new therapies. The company's focus is on addressing unmet medical needs in rare diseases, with primary therapeutic areas in endocrinology and oncology. The TransCon technology is designed to create prodrugs that provide a predictable and sustained release of an unmodified parent drug, aiming to improve treatment outcomes for patients. Through this platform, Ascendis Pharma is advancing a pipeline of product candidates and is building a fully integrated biopharmaceutical organization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ascendis Pharma A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ascendis Pharma A/S
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ascendis Pharma A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
